Citigroup’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $324K | Sell |
|
|||||
|
2025
Q2 | $1.09M | Sell |
|
|||||
|
2025
Q1 | $3.49M | Buy |
|
|||||
|
2024
Q4 | $3.39M | Buy |
|
|||||
|
2024
Q3 | $1.26M | Buy |
|
|||||
|
2024
Q2 | $777K | Sell |
|
|||||
|
2024
Q1 | $7.99M | Buy |
|
|||||
|
2023
Q4 | $3.99M | Sell |
|
|||||
|
2023
Q3 | $3.6M | Buy |
|
|||||
|
2023
Q2 | $1.32M | Sell |
|
|||||
|
2023
Q1 | $4.59M | Buy |
|
|||||
|
2022
Q4 | $1.8M | Buy |
|
|||||
|
2022
Q3 | $1.72M | Buy |
|
|||||
|
2022
Q2 | $100K | Sell |
|
|||||
|
2022
Q1 | $106K | Sell |
|
|||||
|
2021
Q4 | $4.19M | Buy |
|
|||||
|
2021
Q3 | $1.04M | Buy |
|
|||||
|
2021
Q2 | $37K | Buy |
|